Disease Info Card

T-cell Large Granular Lymphocyte Leukemia

Information about T-cell Large Granular Lymphocyte Leukemia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of T-cell Large Granular Lymphocyte Leukemia

Most recent studies have shown that T-cell Large Granular Lymphocyte Leukemia shares some biological mechanisms with aggressive-nk-cell-leukemia, anemia, aplasia-nos, arthritis, autoimmune-diseases, autoimmune-reaction, chronic-lymphocytic-leukemia, infective-disorder, leukemia, leukemia-t-cell, lymphocytosis, lymphoid-leukemia, lymphoma, lymphoproliferative-disorders, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, pure-red-cell-aplasia, rheumatoid-arthritis, t-cell-lymphoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying T-cell Large Granular Lymphocyte Leukemia, and have been seen in publications frequently: Aging, Cell Activation, Cell Cycle, Cell Death, Cell Development, Cell Differentiation, Cell Growth, Cell Proliferation, Cytokine Production, Cytolysis, Drug Resistance, Glycosylation, Immune Response, Killer Activity, Localization, Lymphocyte Proliferation, Methylation, Pathogenesis, Secretion, T Cell Proliferation

Quite a number of genes have been found to play important roles in T-cell Large Granular Lymphocyte Leukemia, such as B3GAT1, CD2, CD4, CD8A, CTLA4, FAS, FCGR3A, FCGR3B, HLA-DQA1, IL15, IL2, KLRD1, LIPF, NCAM1, NOD2, OSTM1, PPP1R3B, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.